World Health Organization Raises Alert Over Acute Shortage of Weight-Loss Medications
Under 10% of patients eligible to benefit from weight-loss injections including Wegovy are able to get them, states the global health agency as it releases its initial advice on the therapies.
With in excess of 1,000,000,000 individuals worldwide now obese, it is advocating for more widespread and fairer availability to GLP-1 medication.
Based on projections, more than two billion could be living with obesity by 2030 without intervention.
"Our new guidance acknowledges that excess weight is a long-term condition that can be managed with holistic and continuous treatment," stated its chief Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and logistical bottlenecks are major barriers to widespread availability to the treatments that can aid individuals in losing significant body mass, explains the organization.
GLP-1 Therapy Supply Crisis
Even under the present most optimistic outlook, the production of these medications might only reach approximately 100 million people – less than 10% of the global need, per the health organization.
The advice encourages governments and firms to increase availability, through approaches including patent sharing.
The intellectual property rights on a key compound – the core component of a leading brand – is set to lapse in a number of nations in 2026.
The Way Weight-Loss Jabs Operate
The injections replicate a natural hormone to delay gastric emptying, suppress the appetite and increase the sense of being full so people eat less.
People commonly start to lose weight after several weeks of beginning the regular doses.
Studies suggests people may regain a significant portion a year later of halting the drug, when their usual appetite return.
To be overweight or obese elevates your chance for contracting medical conditions, including type 2 diabetes, cardiovascular issues, stroke, and some malignancies.
Excess weight concerns individuals in every country and was responsible for millions of deaths worldwide in 2024, as per the WHO.
